Yat Sun Or
2022
Compensation breakdown
| Non-Equity Incentive Plan | $199,695 |
|---|---|
| Option Awards | $985,114 |
| Salary | $501,250 |
| Stock Awards | $764,324 |
| Other | $19,218 |
| Total | $2,469,600 |
Or received $985.1K in option awards, accounting for 40% of the total pay in 2022.
Or also received $199.7K in non-equity incentive plan, $501.3K in salary, $764.3K in stock awards and $19.2K in other compensation.
Rankings
In 2022, Yat Sun Or's compensation ranked 1,476th out of 5,760 executives tracked by ExecPay. In other words, Or earned more than 74.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,476 out of 5,760 | 74th |
Division Manufacturing | 740 out of 3,136 | 76th |
Major group Chemicals And Allied Products | 289 out of 1,422 | 80th |
Industry group Drugs | 268 out of 1,323 | 80th |
Industry Pharmaceutical Preparations | 191 out of 969 | 80th |
Pay ratio
| Yat Sun Or's Pay | $2,469,600 |
|---|---|
| Median Employee's Pay | $249,345 |
| Pay Ratio | 10to 1 |
In 2022, the annual total compensation of Yat Sun Or was $2,469,600.
The annual total compensation of the median employee at Enanta Pharmaceuticals was $249,345.
The ratio of Yat Sun Or's pay to the pay of median employee was therefore 10 to one.
Or's colleagues
We found four more compensation records of executives who worked with Yat Sun Or at Enanta Pharmaceuticals in 2022.
News
January 20, 2023
January 21, 2022
January 21, 2021
January 17, 2020
January 18, 2019